Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?

Current drug targets - 1 Feb 2013

Kostikas Konstantinos, Bakakos Petros, Papiris Spyros, Stolz Daiana, Celli Bartolome R

Abstract excerpt

Chronic obstructive pulmonary disease (COPD) is a complex, multicomponent disease at the clinical, cellular, and molecular levels. Over the past few years there has been a growing interest in the field of biomarkers in COPD and a large number of studies have evaluated potential candidate molecules in different patient settings. Data on systemic biomarkers from large cohorts, including the well-characterized...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Inflammation
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pulmonary Disease, Chronic Obstructive

Share to Severity of Illness Index

Share to Treatment Outcome

Source

Identifiers

PMID: 23256717
DOI: 10.2174/1389450111314020005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?PMID 23256717Read ↗

Biomarkers for precision medicine in airways disease.Semantic proximity Read ↗

[Biomarkers in COPD--do we need them?].Semantic proximity Read ↗

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and PerspectivesSemantic proximity Read ↗

Biomarkers in the assessment and management of airways diseases.Semantic proximity Read ↗

Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.Semantic proximity Read ↗

Biomarkers in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap.Semantic proximity Read ↗

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.Semantic proximity Read ↗

COPD: definition and phenotypes.Semantic proximity Read ↗

Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.Semantic proximity Read ↗

The potential value of biomarkers in diagnosis and staging of COPD and exacerbations.Semantic proximity Read ↗

Chronic obstructive pulmonary disease (COPD) and COPD-like phenotypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.